Tech · Trending · 1 source
▲ Positive
The FDA wants to pull its approval of a drug. It’s not so easy.
Headline via Ars Technica · First reported 14h ago · Updated 14h ago
The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?
Read the full story at Ars Technica
